-
公开(公告)号:US08431704B2
公开(公告)日:2013-04-30
申请号:US12988891
申请日:2009-04-21
申请人: Christopher John Love , Joseph Elisabeth Leenaerts , Ludwig Paul Cooymans , Donald Alec Lebsack , Bryan James Branstetter , Jason Christopher Rech , Elizabeth Ann Gleason , Jennifer Diane Venable , Danielle Wiener , Deborah Margaret Smith , James Guy Breitenbucher
发明人: Christopher John Love , Joseph Elisabeth Leenaerts , Ludwig Paul Cooymans , Donald Alec Lebsack , Bryan James Branstetter , Jason Christopher Rech , Elizabeth Ann Gleason , Jennifer Diane Venable , Danielle Wiener , Deborah Margaret Smith , James Guy Breitenbucher
IPC分类号: C07D215/38
CPC分类号: C07D401/14 , C07D405/14 , C07D413/14 , C07D471/10 , C07D487/04 , C07D487/08 , C07D491/08
摘要: The present invention is related to novel compounds of formula (I) having P2X7 antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans. (I).
摘要翻译: 本发明涉及具有P2X7拮抗性质的新型式(I)化合物,包含这些化合物的药物组合物,用于制备这些化合物的化学方法及其用于治疗或预防与动物中P2X7受体活性有关的疾病的用途,特别是 人类。 (一世)。
-
公开(公告)号:US20110092481A1
公开(公告)日:2011-04-21
申请号:US12988891
申请日:2009-04-21
申请人: Christopher John Love , Joseph Elisabeth Leenaerts , Ludwig Paul Cooymans , Donald Alec Labsack , Bryan James Branstetter , Jason Christopher Rech , Elizabeth Ann Gleason , Jennifer Diane Venable , Danielle Wiener , Deborah Margaret Smith , James Guy Breitenbucher
发明人: Christopher John Love , Joseph Elisabeth Leenaerts , Ludwig Paul Cooymans , Donald Alec Labsack , Bryan James Branstetter , Jason Christopher Rech , Elizabeth Ann Gleason , Jennifer Diane Venable , Danielle Wiener , Deborah Margaret Smith , James Guy Breitenbucher
IPC分类号: A61K31/4709 , C07D401/14 , C07D413/14 , A61K31/553 , A61K31/55 , A61K31/5377 , A61K31/506 , A61K31/496 , A61K31/4725 , A61P43/00
CPC分类号: C07D401/14 , C07D405/14 , C07D413/14 , C07D471/10 , C07D487/04 , C07D487/08 , C07D491/08
摘要: The present invention is related to novel compounds of formula (I) having P2X7 antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans. (I)
摘要翻译: 本发明涉及具有P2X7拮抗性质的新型式(I)化合物,包含这些化合物的药物组合物,用于制备这些化合物的化学方法及其用于治疗或预防与动物中P2X7受体活性有关的疾病的用途,特别是 人类。 (一世)
-